Literature DB >> 26784140

Is Hepatocellular Cancer the Same Disease in Alcoholic and Nonalcoholic Fatty Liver Diseases?

Nicolas Goossens1, Yujin Hoshida2.   

Abstract

Entities:  

Keywords:  Nonalcoholic Steatohepatitis; PNPLA3; Prognosis; Risk Factor; Single-Nucleotide Polymorphism

Mesh：

Year:  2016        PMID： 26784140      PMCID： PMC5120760          DOI： 10.1053/j.gastro.2016.01.006

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  35 in total

1.  Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.

Authors:  Pierre Nahon; Angela Sutton; Pierre Rufat; Marianne Ziol; Gabriel Thabut; Pierre-Olivier Schischmanoff; Dominique Vidaud; Nathalie Charnaux; Philippe Couvert; Nathalie Ganne-Carrie; Jean-Claude Trinchet; Liliane Gattegno; Michel Beaugrand
Journal:  Gastroenterology       Date:  2007-10-26       Impact factor: 22.682

2.  Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.

Authors:  Faten Charni; Angela Sutton; Pierre Rufat; Christelle Laguillier; Abdellah Mansouri; Richard Moreau; Nathalie Ganne-Carrié; Jean-Claude Trinchet; Michel Beaugrand; Nathalie Charnaux; Pierre Nahon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-05-24       Impact factor: 4.254

3.  Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.

Authors:  Sandrine Boyault; David S Rickman; Aurélien de Reyniès; Charles Balabaud; Sandra Rebouissou; Emmanuelle Jeannot; Aurélie Hérault; Jean Saric; Jacques Belghiti; Dominique Franco; Paulette Bioulac-Sage; Pierre Laurent-Puig; Jessica Zucman-Rossi
Journal:  Hepatology       Date:  2007-01       Impact factor: 17.425

4.  Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis.

Authors:  Pierre Nahon; Angela Sutton; Pierre Rufat; Marianne Ziol; Hassan Akouche; Christelle Laguillier; Nathalie Charnaux; Nathalie Ganne-Carrié; Véronique Grando-Lemaire; Gisèle N'Kontchou; Jean-Claude Trinchet; Liliane Gattegno; Dominique Pessayre; Michel Beaugrand
Journal:  Hepatology       Date:  2009-11       Impact factor: 17.425

5.  Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease.

Authors:  Sahil Mittal; Hashem B El-Serag; Yvonne H Sada; Fasiha Kanwal; Zhigang Duan; Sarah Temple; Sarah B May; Jennifer R Kramer; Peter A Richardson; Jessica A Davila
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-18       Impact factor: 11.382

6.  Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis.

Authors:  Valérie Paradis; Stéphane Zalinski; Emna Chelbi; Nathalie Guedj; Françoise Degos; Valérie Vilgrain; Pierre Bedossa; Jacques Belghiti
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

Review 7.  How the risk of liver cancer changes after alcohol cessation: a review and meta-analysis of the current literature.

Authors:  Gawain A Heckley; Johan Jarl; Benedict O Asamoah; Ulf G-Gerdtham
Journal:  BMC Cancer       Date:  2011-10-13       Impact factor: 4.430

8.  Integrative genomic signatures of hepatocellular carcinoma derived from nonalcoholic Fatty liver disease.

Authors:  Itziar Frades; Erik Andreasson; Jose Maria Mato; Erik Alexandersson; Rune Matthiesen; Maria Luz Martínez-Chantar
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

9.  Clinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinoma.

Authors:  Sang Soo Lee; Sook-Hyang Jeong; Young-Sang Byoun; Seong Min Chung; Mun Hyuk Seong; Hyung Rae Sohn; Bo-Young Min; Eun Sun Jang; Jin-Wook Kim; Guan Jung Park; Yoon Jin Lee; Kyoung Ho Lee; Soyeon Ahn
Journal:  BMC Cancer       Date:  2013-07-08       Impact factor: 4.430

10.  Hepatocellular Carcinoma Management in Nonalcoholic Fatty Liver Disease Patients: Applicability of the BCLC Staging System.

Authors:  Luciana Kikuchi; Claudia P Oliveira; Mario R Alvares-da-Silva; Claudia M Tani; Marcio A Diniz; Jose T Stefano; Aline L Chagas; Regiane S S M Alencar; Denise C P Vezozzo; Gilmar R Santos; Priscila B Campos; Venancio Af Alves; Vlad Ratziu; Flair J Carrilho
Journal:  Am J Clin Oncol       Date:  2016-10       Impact factor: 2.339
View more
  9 in total

1.  Independent and additive effects of PNPLA3 and TM6SF2 polymorphisms on the development of non-B, non-C hepatocellular carcinoma.

Authors:  Maneerat Raksayot; Natthaya Chuaypen; Apichaya Khlaiphuengsin; Nutcha Pinjaroen; Sombat Treeprasertsuk; Yong Poovorawan; Yasuhito Tanaka; Pisit Tangkijvanich
Journal:  J Gastroenterol       Date:  2018-11-30       Impact factor: 7.527

2.  Commonalities and Distinctions Between Alcoholic and Nonalcoholic Fatty Liver Disease.

Authors:  Arun J Sanyal; Philippe Mathurin; Laura A Nagy
Journal:  Gastroenterology       Date:  2016-05-04       Impact factor: 22.682

Review 3.  Th17 cells in the liver: balancing autoimmunity and pathogen defense.

Authors:  Nobuhito Taniki; Nobuhiro Nakamoto; Po-Sung Chu; Masataka Ichikawa; Toshiaki Teratani; Takanori Kanai
Journal:  Semin Immunopathol       Date:  2022-02-24       Impact factor: 11.759

4.  Tailored algorithms for hepatocellular carcinoma surveillance: Is one-size-fits-all strategy outdated?

Authors:  Nicolas Goossens; C Billie Bian; Yujin Hoshida
Journal:  Curr Hepatol Rep       Date:  2017-02-01

Review 5.  Translational Aspects of Diet and Non-Alcoholic Fatty Liver Disease.

Authors:  Nicolas Goossens; François R Jornayvaz
Journal:  Nutrients       Date:  2017-09-28       Impact factor: 5.717

6.  Polymorphism in the Promoter Region of NFE2L2 Gene Is a Genetic Marker of Susceptibility to Cirrhosis Associated with Alcohol Abuse.

Authors:  Kemper Nunes Dos Santos; Rodrigo M Florentino; Andressa França; Antônio Carlos Melo Lima Filho; Marcone Loiola Dos Santos; Dabny Missiaggia; Matheus de Castro Fonseca; Igor Brasil Costa; Paula Vieira Teixeira Vidigal; Michael H Nathanson; Fernanda de Oliveira Lemos; M Fatima Leite
Journal:  Int J Mol Sci       Date:  2019-07-23       Impact factor: 5.923

7.  Multiple Roles of Black Raspberry Anthocyanins Protecting against Alcoholic Liver Disease.

Authors:  Ting Xiao; Zhonghua Luo; Zhenghong Guo; Xude Wang; Meng Ding; Wei Wang; Xiangchun Shen; Yuqing Zhao
Journal:  Molecules       Date:  2021-04-16       Impact factor: 4.411

8.  IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.

Authors:  Hsiao-Yen Ma; Gen Yamamoto; Jun Xu; Xiao Liu; Daniel Karin; Ju Youn Kim; Ludmil B Alexandrov; Yukinori Koyama; Takahiro Nishio; Chris Benner; Sven Heinz; Sara B Rosenthal; Shuang Liang; Mengxi Sun; Gabriel Karin; Peng Zhao; Pnina Brodt; Iain H Mckillop; Oswald Quehenberger; Ed Dennis; Alan Saltiel; Hidekazu Tsukamoto; Bin Gao; Michael Karin; David A Brenner; Tatiana Kisseleva
Journal:  J Hepatol       Date:  2019-12-31       Impact factor: 25.083

9.  Diabetes and Hepatocellular Carcinoma: Incidence Trends and Impact of Liver Disease Etiology.

Authors:  Iliana Doycheva; Talan Zhang; Waseem Amjad; Paul J Thuluvath
Journal:  J Clin Exp Hepatol       Date:  2019-11-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.